First, miR-22 is predicted to target Rcor1, a crucial regulator of neuronal gene expression; the Restrictive Element 1 Silencing Transcription Factor pathway has been shown to be hyperactive in HD, leading to a large-scale repression of neuronal genes in affected neurons [11]. Here, RCOR1 is linked to Huntington disease.